Cohen's SAC Capital Boosts Stake in Pharmion (PHRM) to 8.3%
In an amended 13D filing on Pharmion Corporation (Nasdaq: PHRM), Steven Cohen's SAC Capital disclosed an 8.3% stake stake (3,074,700 shares) in the company. This is up from the 7.1% stake disclosed in the original 13D.
Cohen's firm didn't make any direct requests of Pharmion, which is currently in a cash/stock merger agreement with Celgene Corporation (Nasdaq: CELG).
SAC Capital is a $14 billion multi-strategy hedge fund founded by Steven A. Cohen.
Cohen's firm didn't make any direct requests of Pharmion, which is currently in a cash/stock merger agreement with Celgene Corporation (Nasdaq: CELG).
SAC Capital is a $14 billion multi-strategy hedge fund founded by Steven A. Cohen.
You May Also Be Interested In
Create E-mail Alert Related Categories
13DsRelated Entities
SAC Capital, Steven A. CohenSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
